ASX:LBT

LBT Innovations (LBT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
857,080 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
10.81%
Price Target
N/A
LBT stock logo

About LBT Innovations Stock (ASX:LBT)

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

LBT Stock News Headlines

Is LBT Innovations (ASX:LBT) Weighed On By Its Debt Load?
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...
AKVA group ASA: Q1 2022 financial reporting
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...
Does LBT Innovations (ASX:LBT) Have A Healthy Balance Sheet?
See More Headlines
Receive LBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LBT Innovations and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2019
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
$-21,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.98 million

Miscellaneous

Outstanding Shares
1,330,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.30
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Brenton John Barnes
    CEO, MD & Director
  • Mr. Raymond Robert Ridge B.A.
    BA (Acc), C.A., CA, GIA (cert), CFO, Company Secretary & Director
  • Dr. Steven Giglio
    Scientific Director
  • Mr. Jack Brown
    Corporate Development Director

LBT Stock Analysis - Frequently Asked Questions

How were LBT Innovations' earnings last quarter?

LBT Innovations Limited (ASX:LBT) posted its earnings results on Tuesday, February, 26th. The company reported ($0.01) earnings per share (EPS) for the quarter.

This page (ASX:LBT) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners